Citadel

Citadel is a leading global alternative investment manager (hedge fund) founded by Kenneth C. Griffin. The firm is one of the world's largest and most successful multi-strategy hedge funds, known for its data-driven and quantitative approach to the financial markets. It operates across multiple asset classes, including equities, fixed income and macro, commodities, and credit. While not a pharmaceutical manufacturer, Citadel is a critical player in the life sciences industry through its healthcare-focused investment units, Surveyor Capital and Ashler Capital. These divisions specialize in fundamental research-driven investments in biopharmaceutical, medical device, and healthcare services companies, frequently leading or participating in major Series financing rounds and Initial Public Offerings (IPOs) for emerging biotech firms.